We use cookies on our website. Some of them are essential, while others help us to improve this website and your experience.
Essential cookies enable basic functions and are necessary for the website to function properly.
Speichert die Einstellungen der Besucher, die in der Cookie-Consent-Box ausgewählt wurden.
Schützt vor Cross-Site-Request-Forgery Angriffen.
Speichert die aktuelle PHP-Session.
reCAPTCHA ist ein freier Captcha-Dienst von Google, der unsere Webseite vor Spam-Software und den Missbrauch durch nicht-menschliche Besucher schützt.
Third-party content, such as stock widgets, is blocked by default. If third-party cookies are accepted, access to this content no longer requires manual consent.
We use the provider TradingView to display stock charts. This provider uses additional cookies to analyze its services.
Provider: Tradingview
Retention period: Session, up to 2 years
Technical name: _sp_id.*,_sp_ses.*,_gid,_ga
You can subscribe to our newsletter, for this we use the services of EQS. When registering, this provider uses various cookies to analyze the use of its services.
Proposed dividend of EUR 5.00 per share (previous year: EUR 1.20), to be approved at the Annual General Meeting on 9 July 2026
Net loss for the period of EUR 52.0 million (same quarter last year: EUR 20.0 million), primarily due to the non-cash fair value measurement of the investment in M1 Kliniken AG
Equity ratio remains very high: 91.9% (previous year, 31 December 2025: 94.3%)
M1 Kliniken AG’s beauty division reports a strong first quarter of 2026: revenue up 5.7% to EUR 27.1 million, EBIT up 37.6% to EUR 9.2 million, EBIT margin at 33.9% (same quarter last year: 26.0%)
At today's balance sheet meeting, the Supervisory Board of MPH Health Care AG (ISIN: DE000A289V03) approved the annual financial statements and the consolidated financial statements of the Company for the 2025 financial year, as submitted by the Management Board, in accordance with §§ 171, 172 AktG. The annual financial statements are thereby adopted pursuant to § 172 AktG.
The Supervisory Board and the Management Board today resolved to propose to the Annual General Meeting a dividend of EUR 5.00 per dividend-bearing share.
The 2025 Annual Report of MPH Health Care AG is expected to be published on 27 May 2026.
MPH Health Care AG (ISIN: DE000A289V03) announces its preliminary IFRS consolidated results for the third quarter of 2025. According to this, equity decreased by 30% from EUR 277.9 million as of 31 December 2024 to EUR 194.2 million as of 30 September 2025. Net asset value (NAV) per share fell from EUR 64.90 (31 December 2024) to EUR 45.36 as of 30 September 2025
MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated results for the first half-year of 2025. Accordingly, equity decreased by 26% from EUR 277.9 million as of 31 December 2024 to EUR 205.1 million as of 30 June 2025. The net asset value (NAV) per share fell from EUR 64.90 (31 December 2024) to EUR 47.91 as of 30 June 2025.
MPH Health Care AG announces the preliminary IFRS consolidated result for the 2024 financial year. Accordingly, equity increased by 10.7% from EUR 251.0 million to EUR 277.9 million. The net asset value (NAV) per share rose from EUR 58.62 (31 December 2023) to EUR 64.90 as of 31 December 2024.
MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated result for the first nine months of the 2024 financial year. Accordingly, equity increased by EUR 49.3 million to EUR 300.3 million as of 30 September 2024 (previous year 31 December 2023: EUR 251.0 million). The net asset value (NAV) per share increased by 39% year-over-year from EUR 50.38 (30/09/2023) to EUR 70.14 as of 30/09/2024.
MPH Health Care AG announces the preliminary IFRS consolidated result for the first half of 2024. Accordingly, equity increased from EUR 251.0 million to EUR 325.5 million. The net asset value (NAV) per share rose by 58% from EUR 48.12 (30.06.2023) to EUR 76.02 as of 30th June 2024.
MPH Health Care AG announces the preliminary IFRS consolidated results for the first quarter of 2024. Accordingly, the net asset value (NAV) per share increased from EUR 43.91 at the same time last year to EUR 58.77 as of March 31, 2024. This corresponds to an increase of around 34%.
Menu
